---
figid: PMC8989389__vdac012f0001
figtitle: 'Malignant glioma subset from actuate 1801: Phase I/II study of 9-ING-41,
  GSK-3B inhibitor, monotherapy or combined with chemotherapy for refractory malignancies'
organisms:
- Homo sapiens
- Mus musculus
pmcid: PMC8989389
filename: vdac012f0001.jpg
figlink: /pmc/articles/PMC8989389/figure/F1/
number: F1
caption: 'Mechanism of Action of GSK-3ß and 9-ING-41 (GSK-3ß inhibitor). 9-ING-41
  is a small-molecule potent selective GSK-3β inhibitor with preclinical antitumor
  activity against several tumor types. 9-ING-41 downregulates oncogenic pathways
  that lead to chemotherapy and drug resistance including: (1) NF-κB pathway; (2)
  DNA damage response (DDR) pathway. Suppressing these pathways may restore responsiveness
  of resistant tumors to chemotherapy and radiation therapy.'
papertitle: 'Malignant glioma subset from actuate 1801: Phase I/II study of 9-ING-41,
  GSK-3β inhibitor, monotherapy or combined with chemotherapy for refractory malignancies.'
reftext: Yazmin Odia, et al. Neurooncol Adv. 2022 Jan-Dec;4(1):vdac012.
year: '2022'
doi: 10.1093/noajnl/vdac012
journal_title: Neuro-oncology Advances
journal_nlm_ta: Neurooncol Adv
publisher_name: Oxford University Press
keywords: gliomas | GSK-3β | 9-ING-41 | lomustine | phase I trial
automl_pathway: 0.899067
figid_alias: PMC8989389__F1
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC8989389__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8989389__vdac012f0001.html
  '@type': Dataset
  description: 'Mechanism of Action of GSK-3ß and 9-ING-41 (GSK-3ß inhibitor). 9-ING-41
    is a small-molecule potent selective GSK-3β inhibitor with preclinical antitumor
    activity against several tumor types. 9-ING-41 downregulates oncogenic pathways
    that lead to chemotherapy and drug resistance including: (1) NF-κB pathway; (2)
    DNA damage response (DDR) pathway. Suppressing these pathways may restore responsiveness
    of resistant tumors to chemotherapy and radiation therapy.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Gsk3b
  - Ikbkb
  - Nfkbib
  - Nfkb1
  - Rela
  - Gorasp1
  - Cdc37
  - Lsp1
  - Pold2
  - Cd40
  - Dctn2
  - Bcl2
  - Xiap
  - Bc1
  - Bc1-ps1
  - Igkv1-136
  - GSK3B
  - IKBKB
  - GSK3A
  - NFKB1
  - RELA
  - SYT1
  - GORASP1
  - WNK1
  - CD40
  - ARHGEF7
  - ASCC1
  - H3P40
  - BCL2
  - XIAP
  - CHMP2A
  - DDR1
  - DDR2
---
